Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Nobuko Hijiya, Blythe Thomson, Michael S. Isakoff, Lewis B. Silverman, Peter G. Steinherz, Michael J. Borowitz, Richard Kadota, Todd Cooper, Violet Shen, Gary Dahl, Jaideep V. Thottassery, Sima Jeha, Kelly Maloney, Jo-Anne Paul, Elly Barry, William L. Carroll, Paul S. Gaynon

Blood (2011) 118 (23): 6043–6049.

https://doi.org/10.1182/blood-2011-08-374710

Published: 2011

Journal Articles

Phase 2 Results of Clofarabine In Combination with Etoposide and Cyclophosphamide In Pediatric Patients with Refractory or Relapsed Acute Lymphoblastic Leukemia

Nobuko Hijiya, MD, Jo-Anne Paul, Michael J. Borowitz, MD, PhD, Blythe Thomson, MD, Michael Isakoff, MD, Lewis B. Silverman, MD, Peter G Steinherz, MD, Richard Kadota, MD, Joseph G Pressey, MD, Violet Shen, MD, Roland Chu, MD, Todd Cooper, DO, Sima Jeha, MD, Bassem I. Razzouk, MD, Michael E. Rytting, MD, Elly Barry, MD, MMSc, William L. Carroll, MD, Paul Gaynon, MD

Blood (2010) 116 (21): 866.

https://doi.org/10.1182/blood.V116.21.866.866

Published: 2010

Journal Articles

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

Michael A. Pulsipher, Kenneth M. Boucher, Donna Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, Richard Kadota

Blood (2009) 114 (7): 1429–1436.

https://doi.org/10.1182/blood-2009-01-196303

Published: 2009

Includes: Supplemental data

Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD

Blood (2008) 112 (11): 4393.

https://doi.org/10.1182/blood.V112.11.4393.4393

Published: 2008

Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD

Blood (2008) 112 (11): 4399.

https://doi.org/10.1182/blood.V112.11.4399.4399

Published: 2008

Journal Articles

Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia

Nobuko Hijiya, MD, Paul S. Gaynon, MD, Manuel Fernandez, Lewis B. Silverman, MD, Blythe Thomson, MD, Roland Chu, Todd Cooper, DO, Richard Kadota, MD, Michael Rytting, M.D., Peter G. Steinherz, MD, Violet Shen, Sima Jeha, MD, Elly Barry, MD, William L. Carroll, MD

Blood (2008) 112 (11): 2925.

https://doi.org/10.1182/blood.V112.11.2925.2925

Published: 2008

Journal Articles

Successful Engraftment Using Varied Stem Cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in High Risk Pediatric Patients Ineligible for Myelablative Therapy: Results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study ONC0313.

Michael A. Pulsipher, Haydar Frangoul, Michel Duval, Rakesh Goyal, Peter J. Shaw, Ann Haight, Richard Kadota, Michael Grimley, Stephan A. Grupp, Morris Kletzel

Blood (2007) 110 (11): 623.

https://doi.org/10.1182/blood.V110.11.623.623

Published: 2007

Journal Articles

A Novel Therapy of Clofarabine in Combination with Etoposide and Cyclophosphamide Shows Activity in Pediatric Patients with Refractory or Relapsed Acute Leukemia.

Nobuko Hijiya, MD, Paul Gaynon, MD, Manuel Fernandez, Michael Rytting, MD, Roland Chu, MD, Elly Barry, MD, Blythe Thomson, MD, Todd Cooper, MD, Richard Kadota, MD, Stanley Chaleff, MD, Peter Steinherz, MD, Rekha Abichandani, MD, William Carroll, MD

Blood (2007) 110 (11): 883.

https://doi.org/10.1182/blood.V110.11.883.883

Published: 2007

Journal Articles

Clofarabine in Children with Refractory/Relapsed Acute Leukemia: Results of 2 Phase II Open Label Studies.

Sima Jeha, Bassem Razzouk, Paul Gaynon, Michael Rytting, Richard Kadota, Susan Rheingold, Lori Luchtman-Jones, Robert Arceci, Peter Steinherz

Blood (2006) 108 (11): 4460.

https://doi.org/10.1182/blood.V108.11.4460.4460

Published: 2006

Journal Articles

Phase II Trials of Clofarabine in Relapsed or Refractory Pediatric Leukemia.

Sima Jeha, MD, Bassem I. Razzouk, MD, Michael E. Rytting, MD, Paul S. Gaynon, MD, Richard Kadota, MD, Susan Rheingold, MD, Lori Luchtman-Jones, MD, Violet Shen, MD, Robert J. Arceci, MD, PhD, Manuel Fernandez, B.S., Steven Weitman, MD, PhD, Peter G. Steinherz, MD

Blood (2004) 104 (11): 684.

https://doi.org/10.1182/blood.V104.11.684.684

Published: 2004

NARROW

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Phase 2 Results of Clofarabine In Combination with Etoposide and Cyclophosphamide In Pediatric Patients with Refractory or Relapsed Acute Lymphoblastic Leukemia

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia

A Novel Therapy of Clofarabine in Combination with Etoposide and Cyclophosphamide Shows Activity in Pediatric Patients with Refractory or Relapsed Acute Leukemia.

Clofarabine in Children with Refractory/Relapsed Acute Leukemia: Results of 2 Phase II Open Label Studies.

Phase II Trials of Clofarabine in Relapsed or Refractory Pediatric Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only